Hydrogenology
Hydrogenology editorial study record

Molecular hydrogen regulates the expression of miR-9, miR-21 and miR-199 in LPS-activated retinal microglia cells

Liu GD, Zhang H, Wang L, Han Q, Zhou SF, Liu P. · International Journal of Ophthalmology. 2013;6(3):280-285.

PreclinicalOther formsPublished 2013
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Four-condition in-vitro retinal-microglia experiment

Research topic

Eye health

Administration classification

Other forms

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Retinal microglia cell line exposed to LPS in culture; no animals or patients were studied.

Sample

Four conditions: control, 100 ng/mL LPS, control plus H₂ medium and LPS plus H₂ medium. qRT-PCR was performed in quadruplicate; a single biological-replicate total was not reported.

Duration

Thirty-six-hour LPS exposure followed by 24-hour H₂-medium treatment.

Intervention

After 36 hours with or without LPS, cells received hydrogen-saturated DMEM/F12 for 24 hours.

Hydrogen form

H₂ dissolved in cell-culture medium. Separate H₂-, O₂- and CO₂-saturated media were mixed; this was not inhaled Brown's gas.

H₂ specification

H₂ medium was prepared under 0.5 MPa and mixed with O₂- and CO₂-saturated media at 75:20:5 by volume. The article reports an initial calibrated H₂ concentration of 1.0×10⁻⁶ and not less than 0.5×10⁻⁶ after 24 hours, but does not state the unit for those two values; O₂-saturated medium is reported as 42 mg/L.

H₂ flow

Not applicable — prepared cell-culture medium, not gas inhalation; preparation gas flow was not reported.

O₂ delivered with H₂

O₂ was co-dissolved via a separate saturated medium and constituted 20% of the combined medium by volume; no O₂ flow was reported.

Comparator

Control and LPS-exposed cells in ordinary medium, plus control cells in H₂-saturated medium.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Cell survival, miR-9, miR-21, miR-199, Myd88, IKK-β, PDCD4 and NF-κB expression.

Reported result

After LPS, H₂ medium was associated with higher cell survival, lower miR-9/miR-21, higher miR-199, lower Myd88/IKK-β and higher PDCD4. NF-κB expression did not differ significantly between LPS and LPS plus H₂, and the control-plus-H₂ condition showed no significant survival change.

Results-extraction completeness

The complete free PMC article was checked for all four conditions, preparation method/composition, ambiguous concentration units, assay replication, positive and null findings, funding and available disclosures.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

In-vitro single-cell-line model, no organism-level outcome, unclear biological-replicate total, missing units for the stated H₂ concentration values and multiple mechanistic comparisons. No funding or conflict statement was identified in the article, so absence is not inferred.

Applies directly to

LPS-activated cultured retinal microglia; it does not establish treatment of retinal disease in humans.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 23826519 · DOI: 10.3980/j.issn.2222-3959.2013.03.05

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Record revision

2026-08-10